摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-[[(dimethylamino)methylene]amino]-3-(2,4,6-triiodophenyl)propionic acid | 5587-89-3

中文名称
——
中文别名
——
英文名称
3-[[(dimethylamino)methylene]amino]-3-(2,4,6-triiodophenyl)propionic acid
英文别名
3-{[(dimethylamino)methylene]amino}-3-(2,4,6-triiodophenyl)propionic acid;ipodate
3-[[(dimethylamino)methylene]amino]-3-(2,4,6-triiodophenyl)propionic acid化学式
CAS
5587-89-3
化学式
C12H13I3N2O2
mdl
MFCD00867958
分子量
597.961
InChiKey
YQNFBOJPTAXAKV-OMCISZLKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    168-169° (dec 225°)
  • 沸点:
    579.8±60.0 °C(Predicted)
  • 密度:
    2.2000 (rough estimate)

计算性质

  • 辛醇/水分配系数(LogP):
    3.74
  • 重原子数:
    19.0
  • 可旋转键数:
    5.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    52.9
  • 氢给体数:
    1.0
  • 氢受体数:
    2.0

安全信息

  • 危险等级:
    IRRITANT
  • 海关编码:
    2925290090

制备方法与用途

化学性质

磺泊酸是一种白色结晶。熔点为168-169℃,225℃时分解。它溶于甲醇、乙醇、丙酮和稀硫酸。其钠盐为磺泊酸钠(C₁₂H₁₂I₃N₂NaO₂),也被称为Ipodate sodium或Biloptin,Oragrafin sodium。该钠盐是白色叶状结晶,熔点在303-304℃(分解)。它易溶于水和甲醇、乙醇,但在二甲基甲酰胺中易溶,在丙酮和乙醚中不溶解。

用途

磺泊酸是一种口服胆囊、胆管造影药。其毒性较低,极少产生副作用,并且在正常剂量下对肝病、骨肠病及胆道疾病患者都是安全的。它可以提供良好的显影效果,无需经过胆囊浓缩即可清晰显示胆管与胆囊。对于需要快速胆囊造影的情况,在服药2.5-3小时后,即可达到所需的显影程度。

生产方法

磺泊酸的生产方法包括由间硝基苯甲醛与乙酐缩合、用铝镍合金催化氢化还原、碘化以及与DMF缩合而成盐而制得碘泊酸钠。

文献信息

  • ANTHELMINTIC COMPOUNDS AND COMPOSITIONS AND METHOD OF USING THEREOF
    申请人:Meng Charles Q.
    公开号:US20140142114A1
    公开(公告)日:2014-05-22
    The present invention relates to novel anthelmintic compounds of formula (I) below: wherein Y and Z are independently a bicyclic carbocyclic or a bicyclic heterocyclic group, or one of Y or Z is a bicyclic carbocyclic or a bicyclic heterocyclic group and the other of Y or Z is alkyl, alkenyl, alkynyl, cycloalkyl, phenyl, heterocyclyl or heteroaryl, and variables X 1 , X 2 , X 3 , X 4 , X 5 , X 6 , X 7 and X 8 are as defined herein. The invention also provides for veterinary compositions comprising the anthelmintic compounds of the invention, and their uses for the treatment and prevention of parasitic infections in animals.
    本发明涉及以下式(I)的新型驱虫化合物: 其中 Y和Z分别是双环碳环或双环杂环基团,或者Y或Z中的一个是双环碳环或双环杂环基团,另一个是烷基,烯基,炔基,环烷基,苯基,杂环基或杂芳基,以及变量X 1 ,X 2 ,X 3 ,X 4 ,X 5 ,X 6 ,X 7 和X 8 如本文所定义。本发明还提供了包含本发明的驱虫化合物的兽药组合物,以及它们用于治疗和预防动物寄生虫感染的用途。
  • [EN] ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS<br/>[FR] COMPOSÉS DEPSIPEPTIDIQUES ANTHELMINTHIQUES
    申请人:MERIAL INC
    公开号:WO2018093920A1
    公开(公告)日:2018-05-24
    The present invention provides cyclic depsipeptide compounds of formula (I) wherein the stereochemical configuration of at least one carbon atom bearing the groups Cy1, Cy2, R1, R2, R3, R4, Ra and Rb is inverted compared with the naturally occurring cyclic depsipeptide PF1022A. The invention also provides compositions comprising the compounds that are effective against parasites that harm animals. The compounds and compositions may be used for combating parasites in or on mammals and birds. The invention also provides for an improved method for eradicating, controlling and preventing parasite infestation in birds and mammals.
    本发明提供了公式(I)的环状脱氨肽化合物,其中至少一个碳原子的立体化学构型与自然存在的环状脱氨肽PF1022A的基团Cy1、Cy2、R1、R2、R3、R4、Ra和Rb相比发生了倒置。该发明还提供了包含这些化合物的组合物,对危害动物的寄生虫具有有效性。这些化合物和组合物可用于对抗哺乳动物和鸟类体内或体表的寄生虫。该发明还提供了一种改进的方法,用于根除、控制和预防鸟类和哺乳动物的寄生虫感染。
  • GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS
    申请人:South Dakota Board of Regents
    公开号:US20200048305A1
    公开(公告)日:2020-02-13
    The present invention describes compositions containing cholesterol-linker-glutathione conjugates for targeting the brain by overcoming barrier entry to the CNS through the blood brain barrier (BBB), including micelle and liposome forms of such compositions. In addition, methods for treating subjects by administering such compositions are also disclosed.
    本发明描述了含有胆固醇-连接剂-谷胱甘肽共轭物的组合物,通过克服血脑屏障(BBB)进入中枢神经系统的屏障入口,包括这些组合物的胶束和脂质体形式。此外,还公开了通过给予这些组合物治疗受试者的方法。
  • [EN] ANTI PARASITIC DIHYDROAZOLE COMPOUNDS AND COMPOSITIONS COMPRISING SAME<br/>[FR] DIHYDROAZOLES ANTIPARASITAIRES ET COMPOSITIONS LES INCLUANT
    申请人:MERIAL LTD
    公开号:WO2011075591A1
    公开(公告)日:2011-06-23
    The present invention relates to novel dihydroazole of formula (I) and salts thereof: Wherein R1, A1, A2, G, X and Y are as defined in the description, compositions thereof, processes for their preparation and their uses to prevent or treat parasitic infections or infestations in animals and as pesticides.
    本发明涉及式(I)的新型二氢咪唑及其盐:其中R1、A1、A2、G、X和Y如描述中所定义,以及它们的组合物、制备方法以及它们用于预防或治疗动物寄生虫感染或寄生虫侵袭以及作为杀虫剂的用途。
  • [EN] TYPE III DEIODINASE INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE LA DÉSIODINASE DE TYPE III ET LEURS UTILISATIONS
    申请人:HADASIT MED RES SERVICE
    公开号:WO2015140792A1
    公开(公告)日:2015-09-24
    The present invention relates to compounds that inhibit the activity of Type III deiodinase (DIO3). The present invention further relates to methods for treating or preventing depression, depression associated with other psychiatric or general medical diseases or conditions, condition amenable to treatment with known anti-depressants and cancer, particularly by using the compounds of the invention.
    本发明涉及抑制第三型去碘酶(DIO3)活性的化合物。本发明还涉及治疗或预防抑郁症、与其他精神疾病或一般医学疾病相关的抑郁症、适合使用已知抗抑郁药物治疗的疾病或状况,以及癌症的方法,特别是通过使用本发明的化合物。
查看更多